Variant report
Variant | nsv1031452 |
---|---|
Chromosome Location | chr8:52483852-52516605 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs576064073 | chr8:52483856-52483857 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs543121279 | chr8:52483879-52483880 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs555452904 | chr8:52484000-52484001 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs79232396 | chr8:52484006-52484007 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs28435347 | chr8:52484036-52484037 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs182522009 | chr8:52484040-52484041 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs137991517 | chr8:52484058-52484059 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs562832118 | chr8:52484064-52484065 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs187520484 | chr8:52484073-52484074 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs370037910 | chr8:52484078-52484079 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs564168165 | chr8:52484106-52484107 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs531753594 | chr8:52484109-52484110 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs193083674 | chr8:52484165-52484166 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs185655747 | chr8:52484171-52484172 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs529073759 | chr8:52484210-52484211 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs143493085 | chr8:52484231-52484232 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs188931394 | chr8:52484276-52484277 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs539770373 | chr8:52484284-52484285 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs558104711 | chr8:52484297-52484298 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs569513564 | chr8:52484304-52484305 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs192376868 | chr8:52484325-52484326 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs183625097 | chr8:52484374-52484375 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs536789246 | chr8:52484376-52484377 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs77691540 | chr8:52484394-52484395 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs188686801 | chr8:52484449-52484450 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs531631602 | chr8:52484453-52484454 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs566903798 | chr8:52484470-52484471 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs181423849 | chr8:52484477-52484478 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs546061456 | chr8:52484509-52484510 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs184138976 | chr8:52484520-52484521 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs531559720 | chr8:52484571-52484572 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs543845039 | chr8:52484577-52484578 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs562030699 | chr8:52484602-52484603 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs529421986 | chr8:52484625-52484626 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs4403396 | chr8:52484641-52484642 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs190122695 | chr8:52484668-52484669 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs146013463 | chr8:52484687-52484688 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs111597074 | chr8:52484698-52484699 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs73588737 | chr8:52484732-52484733 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs74527418 | chr8:52484810-52484811 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs551659035 | chr8:52484820-52484821 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs569938423 | chr8:52484824-52484825 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs536642718 | chr8:52484861-52484862 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs7838285 | chr8:52484892-52484893 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs564704932 | chr8:52484898-52484899 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs567235995 | chr8:52484904-52484905 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs71513535 | chr8:52484943-52484944 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs60766183 | chr8:52484984-52484985 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs572271919 | chr8:52484998-52484999 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs539654714 | chr8:52485021-52485022 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Developmental delay | 21373258 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Esophageal cancer | 20955586 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 20164920 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:52483400-52488400 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
2 | chr8:52496800-52497200 | Enhancers | Skeletal Muscle Female | skeletal muscle |
3 | chr8:52496800-52502800 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
4 | chr8:52498000-52498600 | Enhancers | Esophagus | oesophagus |
5 | chr8:52498400-52498800 | Enhancers | Left Ventricle | heart |
6 | chr8:52498800-52499200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
7 | chr8:52498800-52506200 | Weak transcription | Left Ventricle | heart |
8 | chr8:52499200-52502400 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
9 | chr8:52500400-52501400 | Enhancers | Brain Germinal Matrix | brain |
10 | chr8:52502400-52502800 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
11 | chr8:52502400-52502800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
12 | chr8:52502400-52502800 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
13 | chr8:52502400-52503400 | Enhancers | NH-A | brain |
14 | chr8:52502600-52503000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
15 | chr8:52502600-52503000 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
16 | chr8:52502600-52503000 | Enhancers | Right Ventricle | heart |
17 | chr8:52506200-52506400 | Enhancers | Left Ventricle | heart |
18 | chr8:52506400-52506800 | Enhancers | Fetal Kidney | kidney |
19 | chr8:52511200-52511600 | Active TSS | Primary T killer memory cells from peripheral blood | blood |
20 | chr8:52514200-52514800 | Active TSS | Aorta | Aorta |
21 | chr8:52514800-52518600 | Weak transcription | Aorta | Aorta |